Clinical Trials Directory

Trials / Completed

CompletedNCT01062971

Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide

Comparative Clinical Study of The Safety And Efficacy of A New Fixed-Combination of Timolol-Brimonidine-Dorzolamide In Patients With Open Angle Glaucoma Or Ocular Hypertension

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
124 (actual)
Sponsor
Laboratorios Sophia S.A de C.V. · Industry
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

To compare intraocular pressure lowering effectiveness of a new fixed combination drug.

Detailed description

This is a multicentric, double blind and prospective clinical study. We will include patients with confirmed diagnosis of primary open-angle glaucoma and/or ocular hypertension, with intraocular pressure (IOP) ranging between 21 and 31 mm Hg. Patients will be randomly divided into 2 groups, one of them treated with a new formulation of 0.5% timolol-0.2% brimonidine-2% dorzolamide in fixed combination (Krytantek Ofteno®, Laboratorios Sophia, Mexico) and the other one treated with 0.5% timolol-2% dorzolamide fixed combination (Cosopt®, MSD Laboratories, USA). Patients will receive 1 drop twice a day of either formulations and were examined at days 2, 7, 15, 30, 60, and 90 after initiation of treatment. The primary objective is to compare the efficacy of both formulations, estimated as a decrease in IOP. A Goldmann applanation tonometer will be used for IOP determination.

Conditions

Interventions

TypeNameDescription
DRUGdorzolamide-timolol-brimonidinePatients will be randomly divided into 2 groups, one of them treated with a new formulation of 0.5% timolol-0.2% brimonidine-2% dorzolamide in fixed combination (Krytantek Ofteno®, Laboratorios Sophia, Mexico) and the other one treated with 0.5% timolol-2% dorzolamide fixed combination (Cosopt®, MSD Laboratories, USA). Patients will received 1 drop twice a day of either formulations.

Timeline

Start date
2006-02-01
Primary completion
2007-08-01
Completion
2008-06-01
First posted
2010-02-04
Last updated
2019-08-01
Results posted
2019-08-01

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT01062971. Inclusion in this directory is not an endorsement.